D-Nav Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Liquidation

D-Nav General Information

Description

Developer of a diabetes insulin guidance system designed to autonomously adjust insulin doses directly to the patient. The company's technology automatically interprets patient data and independently initiates insulin management that helps people with type 2 diabetes adjust their insulin doses according to their body's changing insulin needs, enabling patients to monitor their diabetes levels digitally and maximize insulin effectiveness resulting in improved glycemic control.

Contact Information

Website
www.d-nav.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 24 Frank Lloyd Wright Drive
  • Suite L-4000
  • Ann Arbor, MI 48105
  • United States
+1 (734)
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Services
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 24 Frank Lloyd Wright Drive
  • Suite L-4000
  • Ann Arbor, MI 48105
  • United States
+1 (734)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

D-Nav Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation 04-Nov-2024 Completed Bankruptcy: Liquidation
10. Later Stage VC (Series B) 03-May-2023 Completed Generating Revenue
9. Later Stage VC 26-Jan-2021 Completed Generating Revenue
8. Secondary Transaction - Private Completed Generating Revenue
7. Debt - General 28-Sep-2020 Completed Generating Revenue
6. Debt - PPP 13-Apr-2020 Completed Generating Revenue
5. Later Stage VC 18-Nov-2019 Completed Generating Revenue
4. Later Stage VC (Series A) 13-Feb-2017 Completed Generating Revenue
3. Later Stage VC 13-Dec-2013 $1.52M $4.18M Completed Generating Revenue
2. Seed Round 12-Aug-2011 $2.66M $2.66M Completed Generating Revenue
To view D-Nav’s complete valuation and funding history, request access »

D-Nav Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series B-3
Series B-2
Series B-1 3,412,912 $0.000010 8% $0.32 $0.32 1x $0.32 2.68%
Series A 8,658,778 $0.000010 8% $0.63 $0.63 1x $0.54 7.96%
To view D-Nav’s complete cap table history, request access »

D-Nav Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diabetes insulin guidance system designed to autonomously adjust insulin doses directly to the patient. T
Clinics/Outpatient Services
Ann Arbor, MI
52 As of 2023

Denver, CO
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

D-Nav Competitors (5)

One of D-Nav’s 5 competitors is Virta Health, a Venture Capital-Backed company based in Denver, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Virta Health Venture Capital-Backed Denver, CO
Glytec Venture Capital-Backed Boston, MA
Lark Venture Capital-Backed Mountain View, CA
Canary Health Formerly VC-backed Los Angeles, CA
GlySens Venture Capital-Backed San Diego, CA
You’re viewing 5 of 5 competitors. Get the full list »

D-Nav Patents

  • 73

    Total Documents Applications and Grants

  • Total Patents Families

  • 65

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

D-Nav Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3030140-B1 Systems and devices for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus Active 05-Aug-2013
EP-3030140-A2 Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus Active 05-Aug-2013
EP-3030140-A4 Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus Active 05-Aug-2013
AU-2012272781-A1 Systems, methods and devices for achieving glycemic balance Active 24-Jun-2011
ES-2725560-T3 Systems, methods and devices to achieve glycemic balances Active 24-Jun-2011 A61B5/4839
To view D-Nav’s complete patent history, request access »

D-Nav Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

D-Nav FAQs

  • When was D-Nav founded?

    D-Nav was founded in 2008.

  • Where is D-Nav headquartered?

    D-Nav is headquartered in Ann Arbor, MI.

  • What is the size of D-Nav?

    D-Nav has 52 total employees.

  • What industry is D-Nav in?

    D-Nav’s primary industry is Clinics/Outpatient Services.

  • Is D-Nav a private or public company?

    D-Nav is a Private company.

  • What is D-Nav’s current revenue?

    The current revenue for D-Nav is .

  • How much funding has D-Nav raised over time?

    D-Nav has raised $34.2M.

  • Who are D-Nav’s competitors?

    Virta Health, Glytec, Lark, Canary Health, and GlySens are competitors of D-Nav.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »